Aromatase Inhibitor Timing
January 19, 2025 · 6 min read · Editorial Team
Aromatase inhibitors (AIs) control estradiol by blocking the enzyme that converts testosterone to estrogen. Timing them to your testosterone ester’s pharmacokinetics is the single most important — and most commonly mismanaged — aspect of cycle ancillary use.
Match the ester
A long ester (enanthate, cypionate, deca) builds estradiol slowly and persistently. An AI dosed to match (e.g., every 3–4 days) keeps estrogen stable. A short ester (propionate) spikes estradiol fast, requiring closer AI timing.
The over-suppression trap
The most common harm is crashing estradiol by over-dosing an AI. Low estradiol causes joint pain, libido loss, mood disturbance, and lipid damage — often worse than mildly high estrogen.
Anastrozole vs. exemestane vs. letrozole
- Arimidex (Anastrozole) — reversible, moderate potency.
- Aromasin (Exemestane) — suicidal (permanent enzyme inactivation), estrogen rebounds only as new enzyme is synthesized.
- Letrozole — most potent; reserve for stubborn high estradiol.
Plot any of these in the tool to see their relatively short half-lives — another reason dosing cadence matters.